Axel Thors, DO
Vascular Surgery · Overland Park, KSNPI 1629368089
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Johnson & Johnson at 44.8% of the total. Among vascular surgery clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 350 payments — averaging $252.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$40K
- Shockwave Medical, Inc$19K
- Boston Scientific$9K
- Medtronic$7K
- W. L. Gore & Associates, Inc.$5K
- Endologix LLC$3K
- plus $6K from 20 others
Across 21 payments — averaging $889.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Surmodics, Inc.$19K
What the payments were for
- Consulting fees$16,64419%
- Speaking & faculty fees$37,07042%
- Travel & lodging$10,10411%
- Food & beverage$24,09927%
- Education$5901%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 39 | $39,676 |
| Shockwave Medical, Inc | 34 | $18,968 |
| Boston Scientific | 31 | $8,682 |
| Medtronic(2 entities) | 90 | $7,022 |
| W. L. Gore & Associates, Inc. | 45 | $5,101 |
| Endologix LLC | 21 | $3,015 |
| Penumbra, Inc. | 21 | $1,792 |
| Terumo Medical Corporation | 14 | $1,164 |
| Silk Road Medical, Inc. | 10 | $707 |
| Abbott | 7 | $499 |
| Lemaitre Vascular, Inc. | 14 | $459 |
| Philips North America LLC | 4 | $441 |
| Shape Memory Medical Inc. | 2 | $247 |
| Surmodics, Inc. | 2 | $187 |
| Reflow Medical Inc | 1 | $120 |
| Aroa Biosurgery Incorporated | 5 | $119 |
| Edwards Lifesciences | 1 | $103 |
| Janssen Scientific Affairs, LLC | 1 | $45 |
| Inari Medical, Inc. | 1 | $26 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
| Stryker | 1 | $21 |
| Sanara Medtech Inc. | 1 | $21 |
| Angiodynamics, Inc. | 1 | $21 |
| Osiris Therapeutics Inc. | 1 | $16 |
| Centerline Biomedical Inc. | 1 | $15 |
| Cook Medical LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$38,946
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$18,619
- GENERAL - THERAPIES$7,020
- IN.PACT Admiral$2,494
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$1,111
- C3 Delivery System$1,036
- Torus Stent Graft System$1,020
- ENDOCROSS Device$1,020
- Indigo System$1,008
- GORE VIABAHN VBX Balloon Expandable Endo$722
- HawkOne$694
- ENROUTE Transcarotid Neuroprotection System$694
- ENROUTE Transcarotid Stent$552
- ENDURANT IIS$545
- Alto Abdominal Stent Graft System$527
- VIABAHN VBX Balloon Expandable Endoprosthesis$417
- GORE EXCLUDER AAA Endoprosthesis$375
- Penumbra System$356
- ENHANCE Transcarotid Peripheral Access Kit$322
- EXCLUDER Iliac Branch Endoprosthesis$291
How this compares
$88,506 in reported general payments places this provider in the 90th percentile of 22 vascular surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 49 | $46,606 |
| ClopidogrelClopidogrel Bisulfate | 114 | $1,148 |
| Cilostazol | 31 | $976 |
| Atorvastatin Calcium | 18 | $89 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $39,676 | $46,60649 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 22 vascular surgery providers in Kansas.
Other vascular surgery in Overland Park
- Brian McCroskeyOverland Park$35K
- Andrew McChesneyOverland Park$22K
- Scott HardouinOverland Park$19K
- Trevor DoreyOverland Park$4K
- Bernardo MartinezOverland Park$1K
- Edward HigginsOverland Park$658
- Juan Carlos CorreaLeawood$108K
- Byron DecampLawrence$104K
- Chad AmmarWichita$12K
- Steven HutchinsonWichita$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.